Clear Search sequence regions


  • black (1)
  • humans (1)
  • patients (1)
  • valproic acid (7)
  • Sizes of these terms reflect their relevance to your search.

    Valproic acid (VPA) is a medication used to treat multiple neuroscience conditions. It is an inexpensive and useful medication, with a low incidence of adverse drug events. Nonetheless, optimal clinical outcomes require that a series of screening and laboratory steps be followed before the initiation of VPA therapy. An additional aspect of pharmacovigilance is to recognize clinical patterns signaling genetic traits that preclude VPA, background of the black box warnings, targeted assessments, and laboratory monitoring indicated while on VPA. The intention of this article is to provide a focused summary of published information clinically relevant to prescribing and monitoring these patients.

    Citation

    Angela Collins-Yoder, Jordan Lowell. Valproic Acid: Special Considerations and Targeted Monitoring. The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses. 2017 Feb;49(1):56-61

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 28060221

    View Full Text